AIG vs KNSA · P/E 21, rev $13.73B vs P/E 53, rev $677.6M
American International Group Inc (AIG) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
American International Group Inc (AIG) is a insurance - diversified company listed on US.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AIG revenue for 2026-06-30 was $13.73B. Net income was $1.71B. AIG currently screens at market cap $48.97B and trailing P/E 20.6.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
AIG currently screens at market cap $48.97B and trailing P/E 20.6. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the AIG and KNSA stock pages for the full models.
Not investment advice.